Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Balance Sheets

v3.24.2.u1
Condensed Consolidated Balance Sheets - USD ($)
$ in Thousands
Jun. 30, 2024
Dec. 31, 2023
Current assets:    
Cash and cash equivalents $ 78,807 $ 86,411
Restricted cash 3,325 5,650
Inventory, net 27,842 28,776
Prepaid expenses and other current assets 3,352 3,359
Total current assets 113,326 124,196
Restricted cash 502 2,802
Property and equipment, net 7,995 11,625
Operating lease right-of-use assets 7,744 9,612
Other long-term assets 2,208 2,507
Total assets 131,775 150,742
Current liabilities:    
Accounts payable 9,251 8,074
Accrued expenses 11,322 16,020
Deferred revenue 6,886 7,154
Operating lease liabilities, current 1,551 3,489
Other current liabilities 221 306
Total current liabilities 29,231 35,043
Debt, noncurrent 73,404 71,662
Operating lease liabilities, noncurrent 7,149 14,404
Derivative liabilities 11,305 11,511
Total liabilities 121,089 132,620
Commitments and contingencies (Note 6)
Temporary equity, shares issued (in shares) 10,000 10,000
Redeemable convertible preferred stock, $0.0001 par value — 100,000,000 shares authorized at June 30, 2024 and December 31, 2023; 10,000 shares issued and outstanding at June 30, 2024 and December 31, 2023 $ 10,000 $ 10,000
Stockholders’ equity:    
Common stock - $0.0001 par value — 600,000,000 Class A shares authorized at June 30, 2024 and December 31, 2023; 33,501,480 and 32,183,695 shares issued and outstanding at June 30, 2024 and December 31, 2023, respectively; 200,000,000 Class B shares authorized at June 30, 2024 and December 31, 2023; 5,451,745 and 5,724,199 shares issued and outstanding at June 30, 2024 and December 31, 2023, respectively 4 4
Additional paid-in capital 635,224 629,208
Accumulated deficit (634,542) (621,090)
Total stockholders’ equity 686 8,122
Total liabilities, redeemable convertible preferred stock and stockholders’ equity $ 131,775 $ 150,742